Antipodes Partners LTD I Rhythm Technologies, Inc. Transaction History
Antipodes Partners LTD
- $4.06 Billion
- Q3 2025
A detailed history of Antipodes Partners LTD transactions in I Rhythm Technologies, Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 220 shares of IRTC stock, worth $37,580. This represents 0.0% of its overall portfolio holdings.
Number of Shares
220
Previous 255
13.73%
Holding current value
$37,580
Previous $39,000
5.13%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IRTC
# of Institutions
367Shares Held
54.2MCall Options Held
136KPut Options Held
201K-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct20MShares$3.42 Billion1.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.24MShares$553 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.57MShares$439 Million0.67% of portfolio
-
Black Rock Inc. New York, NY2.5MShares$427 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA2.24MShares$382 Million1.11% of portfolio
About iRhythm Technologies, Inc.
- Ticker IRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 30,026,600
- Market Cap $5.13B
- Description
- iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platf...